MiMedx Group
MDXG
17 hedge funds and large institutions have $6.26M invested in MiMedx Group in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
8% more capital invested
Capital invested by funds: $5.79M → $6.26M (+$475K)
6% less funds holding
Funds holding: 18 → 17 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$41K |
| 2 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
+$11.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TIM
Thompson Investment Management
Madison,
Wisconsin
|
-$229K |
| 2 |
TRSOTSOK
Teachers Retirement System of the State of Kentucky
Frankfort,
Kentucky
|
-$156K |
| 3 |
NCM
Next Capital Management
New York
|
-$66K |
| 4 |
Nisa Investment Advisors
St. Louis,
Missouri
|
-$2K |
MDXG Hedge Fund Activity: Q2 2019 in Review
17 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q2 2019, worth a combined $6.26M — up 8.2% from $5.79M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MDXG and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Cambridge Investment Research Advisors, opening a new position worth an estimated $41K. The largest seller was Thompson Investment Management, cutting an estimated $229K.
- 17 institutional investors held MiMedx Group (MDXG) as of Q2 2019, down from 18 in Q1 2019.
- Funds reported $6.26M of MiMedx Group stock for Q2 2019, up 8.2% quarter-over-quarter.
- 1 fund opened new MiMedx Group positions in Q2 2019 and 2 closed out, a net change of -1 holder.
- The largest MiMedx Group buyer in Q2 2019 was Cambridge Investment Research Advisors, an estimated $41K added.
- The largest MiMedx Group seller in Q2 2019 was Thompson Investment Management, an estimated $229K sold.
Based on aggregated 13F filings for Q2 2019.